Abstract
The serotonin (5HT) receptor genes are considered good candidates for Major Depression (MD), Bipolar Disorder (BP), and Obsessive-Compulsive Disorder (OCD). The 5HT1Dβ receptor gene has at least three polymorphisms known: G861C, T-261G, and the functional T371G (Phe-124-Cys). The aim of this study was to investigate for the presence of linkage disequilibrium between the 5HT1Dβ receptor gene and BP. Two hundred and ninety probands with DSM-IV BPI, BPII, or Schizoaffective Disorder (Bipolar type) with their living parents were recruited. Genotyping data for the G861C and T371G polymorphisms were analyzed using the Transmission Disequilibrium Test (TDT). One hundred and sixty triads were informative for the TDT on the G861C polymorphism, which showed no preferential transmission of either allele (chi-square = 0.438, df = 1, p = .508). Only four triads were suitable for the analysis on the T371G variant, with the T allele transmitted once and the G allele transmitted four times to the affected. These findings validate further the results of pharmacological studies excluding a direct involvement of the 5HT1Dβ receptor in the pathogenesis of BP. Further investigations combining genetic and pharmacological strategies are warranted.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
American Psychiatric Association. (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC, American Psychiatric Association
Blier P, de Montigny C . (1998): Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder response. Biol Psychiatry 44: 313–323
Brüss M, Bönisch H, Bühlen M, Nöthen M, Propping P, Göthert M . (1999): Modified ligand binding to the naturally occurring Cys124 variant of the human serotonin 5-HT1B receptor. Pharmacogenetics 9: 95–102
Cleare AJ, Murray RM, Sherwood RA, O'Keane Y . (1998): Abnormal 5HT1D receptor function in major depression: a neuropharmacological challenge study. Psychol Med 28: 295–300
Demchyshyn L, Sunahara RK, Miller K, Teitler M, Hoffman BJ, Kennedy JL, Seeman P, Van Tol HHM, Niznik HB . (1992): A human serotonin 1D receptor variant (5HT1Dβ) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci USA 89: 5522–5526
Dunner DL . (1998): Bipolar Disorder in DSM-IV: impact of inclusion of rapid cycling as a course modifier. Neuropsychopharmacol 19: 189–193
Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES, Berrettini WH, Detera-Wadleigh SD . (1998): Serotonin transporter (5HTT) gene and bipolar affective disorder. Am J Med Genet 81: 37–40
Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, Easton DF, Rubinsztein DC . (1998): Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorder. Am J Med Genet 81: 58–63
Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC . (1995): Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52: 53–60
Gutierrez B, Fananas L, Arranz MJ, Valles V, Guillamat R, van Os J, Collier D . (1996): Allelic association analysis of the 5HT2C receptor gene in bipolar affective disorder. Neurosci Lett 212: 65–67
Huang Y, Grailhe R, Arango V, Hen R, Mann JJ . (1999): Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacol 21: 238–246
Kelsoe JR, Remick RA, Sadovnick AD, Kristbjarnarson H, Flodman P, Spence MA, Morison M, Mroczkowski-Parker Z, Bergesh P, Rapaport MH, Mirow AL, Blakely RD, Helgason T, Egeland JA . (1996): Genetic linkage study of bipolar disorder and the serotonin transporter. Am J Med Genet 67: 215–217
Kiel S, Brüss M, Bönisch H, Göthert M . (2000): Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation. Pharmacogenetics 10: 655–666
Lahiri DK, Nurnberger JI . (1991): A rapid no-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucl Acids Res 19: 5444
Lappalainen J, Dean M, Charbonneau L, Virkkunen M, Linnoila M, Goldman D . (1995): Mapping of the serotonin 5-HT1Dβ autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Genet 60: 157–161
Mahieu B, Souery D, Lipp O, Mendelbaum K, Verheyen G, De Maertelaer V, Van Broeckhoven C, Mendlewicz J . (1997): No association between bipolar disorder and a serotonin receptor (5HT2A) polymorphism. Psychiatry Res 70: 65–69
McGinnis R . (2000): General equations for Pt, Ps, and the power of the TDT and the Affected-Sib-Pair Test. Am J Hum Genet 67: 1340–1347
McGuffin P, Katz R . (1989): The genetics of depression and manic-depressive disorder. Br J Psychiatry 155: 294–304
Meltzer HY . (1989): Serotonergic dysfunction in depression. Br J Psychiatry 8 (suppl):25–31
Mendez de Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Lafer B, Vasquez L, Gentil V, Passos-Bueno MR, Zatz M . (1998): Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. Am J Med Genet 81: 225–227
Mundo E, Bianchi L, Bellodi L . (1997): Efficacy of fluvoxamine, paroxetine and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. J Clin Psychopharmacol 17: 267–271
Mundo E, Walker M, Tims H, Macciardi F, Kennedy JL . (2000a): Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and Bipolar Disorder. Am J Med Genet 96: 379–383
Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL . (2000b): Is the 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am J Psychiatry 157: 1160–1161
Nöthen MM, Erdmann J, Shimron-Abarbanell D, Propping P . (1994): Identification of a genetic variation in the human serotonin 1Dβ receptor gene. Biochem Biophys Res Commun 205: 1194–1200
Nurnberger JI Jr, Gershon ES . (1992): Genetics. In Paykel ES (ed), Handbook of Affective Disorders. London, Churchill Livingstone, pp 131–148
Oruc L, Verheyen GR, Furac I, Jakovljevic M, Ivezic S, Raeymaekers O, Van Broeckhoven C . (1997): Association analysis of the 5HT2C receptor and 5HT transporter genes in Bipolar Disorder. Am J Med Genet 74: 504–506
Peroutka SJ . (1995): Serotonin receptors subtypes. Their evolution and clinical relevance. CNS Drugs 4: 18–28
Potter WZ . (1998): Bipolar depression: specific treatments. J Clin Psychiatry 59 (suppl 18):30–36
Risch N, Merikangas K . (1996): The future of genetic studies on complex human diseases. Science 273: 1516–1517
Spielman RS, McGinnis RE, Ewens WJ . (1993): Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506–516
Vincent JB, Masellis M, Lawrence J, Choi V, Gurling HMD, Phil M, Parikh SV, Kennedy JL . (1999): Genetic association analysis of serotonin system genes in bipolar affective disorders. Am J Psychiatry 156: 136–138
Yatham LN, Zis AP, Lam RW, Tam E, Shiah IS . (1997): Sumatriptan-induced growth hormone release in patients with major depression, mania, and normal controls. Neuropsychopharmacol 17: 258–263
Zhang HY, Ishigaki T, Tani K, Chen K, Shih JC, Miyasato K, Ohara K, Ohara K . (1997): Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 41: 768–773
Zohar J . (1996): Is 5-HT1D involved in obsessive compulsive disorder? Eur Neuropsychopharmacol, 6 (suppl):S4–S5
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mundo, E., Zai, G., Lee, L. et al. The 5HT1Dβ Receptor Gene in Bipolar Disorder: A Family-based Association Study. Neuropsychopharmacol 25, 608–613 (2001). https://doi.org/10.1016/S0893-133X(01)00259-7
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(01)00259-7
Keywords
This article is cited by
-
Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders
Journal of Neural Transmission (2016)
-
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1
BMC Medical Genetics (2014)
-
Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder
Molecular Psychiatry (2003)
-
Polymorphisms in the 5′-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression
Molecular Psychiatry (2003)
-
Substance Abuse Disorder and Major Depression are Associated with the Human 5-HT1B Receptor Gene (HTR1B) G861C Polymorphism
Neuropsychopharmacology (2003)
